Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Amarin Corporation plc

Market Cap 32Cr 28Cr 25Cr 24Cr 45Cr 3.04TCr 45Cr 300.32Cr 117.09Cr 1.48TCr 119.93Cr 117.38Cr 5.12TCr P/E Ratio 2026 *
-435x
P/E Ratio 2027 * 277x
Enterprise Value 15Cr 13Cr 12Cr 11Cr 20Cr 1.38TCr 21Cr 136.93Cr 53Cr 674.09Cr 55Cr 54Cr 2.33TCr EV / Sales 2026 *
0.8x
EV / Sales 2027 * 0.68x
Free-Float
89.38%
Yield 2026 *
-
Yield 2027 * -
1 day+2.28%
1 week+9.40%
Current month+5.18%
1 month+1.46%
3 months-0.65%
6 months+6.13%
Current year+9.21%
1 week 13.92
Extreme 13.92
15.54
1 month 13.6
Extreme 13.6
15.54
Current year 12.96
Extreme 12.96
17.31
1 year 12.3
Extreme 12.3
20.9
3 years 7.08
Extreme 7.08
29.7
5 years 7.08
Extreme 7.08
119.4
10 years 7.08
Extreme 7.08
522.4
Manager TitleAgeSince
Chief Executive Officer 63 04/06/2024
Director of Finance/CFO 42 23/10/2024
Compliance Officer 56 15/11/2023
Director TitleAgeSince
Director/Board Member 63 04/06/2024
Director/Board Member 43 28/02/2023
Director/Board Member 67 28/02/2023
Date Insider Type Main position Quantity % Market Cap.
18/04Fiscal year

Director

2,079 0.0005%
18/04Fiscal year

Director

2,079 0.0005%
18/04Fiscal year

Director

2,079 0.0005%
Change 5-day change 1-year change 3-year change Capi.($)
+2.28%+9.40%+15.02%-40.47% 32Cr
+1.03%+2.30%+55.91%+114.22% 5.64TCr
+2.72%+3.26%+46.05%+44.91% 4.45TCr
+1.12%+2.79%-15.04%-21.68% 2.29TCr
+1.17%+3.85%-0.89%+403.86% 2.12TCr
+3.81%-5.07%+11.00%-30.62% 1.64TCr
+0.15%+2.24%+9.32%-39.30% 1.54TCr
-0.69%+0.82%+27.75%+176.72% 1.34TCr
+5.27%+5.54%+19.65% - 1.24TCr
+1.61%+1.28%+95.75%+205.26% 1.12TCr
Average +1.85%+2.82%+26.45%+90.32% 2.14TCr
Weighted average by Cap. +1.72%+2.38%+32.01%+99.37%

Financials

2026 *2027 *
Net sales 18Cr 16Cr 15Cr 14Cr 25Cr 1.73TCr 26Cr 171.27Cr 67Cr 843.16Cr 68Cr 67Cr 2.92TCr 19Cr 17Cr 15Cr 14Cr 27Cr 1.83TCr 27Cr 181.3Cr 71Cr 892.5Cr 72Cr 71Cr 3.09TCr
Net income -1.5Cr -1.3Cr -1.2Cr -1.12Cr -2.1Cr -142.79Cr -2.13Cr -14Cr -5.5Cr -70Cr -5.64Cr -5.52Cr -240.65Cr 2.21Cr 1.91Cr 1.76Cr 1.65Cr 3.09Cr 210.36Cr 3.14Cr 21Cr 8.11Cr 102.39Cr 8.31Cr 8.13Cr 354.52Cr
Net Debt -17Cr -15Cr -14Cr -13Cr -24Cr -1.65TCr -25Cr -163.4Cr -64Cr -804.39Cr -65Cr -64Cr -2.79TCr -19Cr -16Cr -15Cr -14Cr -26Cr -1.78TCr -27Cr -176.19Cr -69Cr -867.39Cr -70Cr -69Cr -3TCr
Logo Amarin Corporation plc
Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.
Employees
80
Date Price Change Volume
12/26/12 15.24 $ +2.28% 76,197
11/26/11 14.90 $ +0.95% 50,777
10/26/10 14.76 $ -0.87% 81,202
09/26/09 14.89 $ +4.86% 1,80,740
08/26/08 14.20 $ +1.94% 82,124
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
2
Last Close Price
15.24USD
Average target price
12.50USD
Spread / Average Target
-17.98%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMRN Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!